Mr. Xu, Zhiyuan joined Tahota in 2008, who is specialized and experienced on equity capital market, debt capital market, M&A, PE investment, corporate governance, ESOPand served as legal advisor for many large enterprises, listed/listing companies, SOEs, private equity funds, banks/trust/micro-loan companies/guarantee companies. Outstanding clients who is served by Mr. Xu are including but not limit Juma Group, Hongda Group, Lomon Corporation, Minjun Group, Hongda Co.(600331), EM Technology(601208), Crun Co.(002272), YMK(300249), Xingrong Environment (000598), Lihang Tech, Usunhome, Saftower Group, Meridian Capital, Sichuan Trust, Hongxin Securities and CDRC Bank.

2005-2008 Sichuan University Master of law

2001-2005 Southwest Jiaotong University Bachelor of engineering

2008-present Tahota Law Firm, Lawyer/Partner,Deputy Director of Inner

Control Committee of Finance and Securities

1. EM Technology IPO；

2. Winsan Medical substantial acquisition ；

3. Numbers of domestic and oversea IPO cases related to military industry, culture and tourism, chemistry, manufacturing；

4. ESOP of EM Technology(601208) and YMK(300249)；

5. NEEQ listing of GuantanG Design（833712）,Sichuan Saftower（833940）and etc.；

6. As legal advisor for Tibet Yuanchu, Tibet Zhengyao, Tibet Puzheng, Shanghai Junyi and SR Xinyi in respect of applying qualification of PE management company；

7. The M&A of Sichuan Trust and Sichuan Construction Trust；

8. Issue legal opinions for Sichuan Trust in respect of its issuance of products；

9. Issuance various types of debts of Ziyang Kai Li Construction, Naxing Industry, Guangyuan Yuan Tou, Xinjin Transport Investment and etc. ；

10. The assets acquisition between Lanrun Property and Minyu Group(over billion)；

11. The acquisition of education institute from Sichuan Energy Investment；

12. The acquisition of Usunhome in Tibet；

13. Numbers of PE investment of Meridian Capital；

14. The acquisition of oil facilities for subsidiary of China Aviation Fuel；

15. Juma Group B round, B+ round and C roundInvestment；

16. The acquisition between Hillhouse Capital and Huaxing Medicine；

17. Lihang Tech’s pre-IPO investment(150million );

18. Mixed ownership plan and reform ofChongqing Food Co.,Ltd;

19. ESOP of Medical beauty subsidiary of Aist Group。